5
total announcements
524518.BO · 15 min delayed
Krebs Biochemicals & Industries Ltd-$
Krebs Biochemicals & Industries Ltd has published unaudited financial results for the quarter ended 30.06.2026, showing a net profit of Rs. 248.48 lakhs and a total comprehensive income of Rs. 248.48 lakhs.
Krebs Biochemicals & Industries Ltd-$
Krebs Biochemicals & Industries Ltd has announced its unaudited financial results for the 1st quarter ended June 30, 2026, with the Board of Directors approving and taking on record the results and a limited review report by the auditors.
Krebs Biochemicals & Industries Ltd-$
Krebs Biochemicals & Industries Ltd has announced the outcome of its board meeting, where the board approved and took on record the unaudited financial results for the 1st quarter ended June 30, 2026, and the limited review report by the auditors on the unaudited financial results.
Krebs Biochemicals & Industries Ltd-$
Krebs Biochemicals & Industries Ltd has scheduled a Board Meeting on August 6, 2026, to consider and adopt the unaudited financial results for the 1st quarter ended June 30, 2026.
Krebs Biochemicals & Industries Ltd-$
Krebs Biochemicals & Industries Ltd announced the closure of its trading window for dealing in company securities, effective from the close of business hours on June 30, 2026. This closure will remain in effect until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. This measure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and applies to promoters, directors, designated persons, and their immediate relatives.